for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Stryker Corporation

SYK

Latest Trade

215.64USD

Change

2.98(+1.40%)

Volume

311,009

Today's Range

213.62

 - 

216.12

52 Week Range

144.75

 - 

223.45

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
212.66
Open
214.35
Volume
311,009
3M AVG Volume
22.36
Today's High
216.12
Today's Low
213.62
52 Week High
223.45
52 Week Low
144.75
Shares Out (MIL)
374.10
Market Cap (MIL)
79,556.88
Forward P/E
25.90
Dividend (Yield %)
0.98

Next Event

Q3 2019 Stryker Corp Earnings Release

Latest Developments

More

Conformis And Stryker Execute Development, License And Distribution Agreements

Stryker Announces Definitive Agreement To Acquire Mobius Imaging & Cardan Robotics

Stryker Corp Declares A $0.52 Per Share Quarterly Dividend

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company's products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.

Industry

Medical Equipment & Supplies

Contact Info

2825 Airview Blvd

+1.269.3892600

https://www.stryker.com/

Executive Leadership

Kevin A. Lobo

Chairman of the Board, Chief Executive Officer

Timothy J. Scannell

President, Chief Operating Officer

Glenn S. Boehnlein

Chief Financial Officer, Vice President

Viju S. Menon

Group President - Global Quality and Operations

M. Kathryn Fink

Chief Human Resource Officer, Vice President

Key Stats

1.93 mean rating - 29 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

11.3K

2017

12.4K

2018

13.6K

2019(E)

14.9K
EPS (USD)

2016

5.800

2017

6.490

2018

7.310

2019(E)

8.212
Price To Earnings (TTM)
40.57
Price To Sales (TTM)
5.60
Price To Book (MRQ)
6.66
Price To Cash Flow (TTM)
29.02
Total Debt To Equity (MRQ)
71.28
LT Debt To Equity (MRQ)
66.77
Return on Investment (TTM)
9.97
Return on Equity (TTM)
8.31

Latest News

Latest News

Appeals court upholds $254 million patent verdict for Stryker against Zimmer

A federal appeals court on Monday upheld a $254 million patent infringement verdict Stryker Corp won against rival medical device maker Zimmer Biomet Holdings Inc, bringing a likely end to a long-running court battle that previously ended up before the U.S. Supreme Court.

7th Circuit revives claim that Stryker fired worker over harassment complaint

A federal appeals court on Monday revived a retaliation lawsuit against medical device maker Stryker Corp by a former employee who says she was fired for reporting that a sales manager had sexually harassed a coworker.

Stryker to pay $7.8 million to settle Foreign Corrupt Practices Act charges

Medical device company Stryker Corp. will pay $7.8 million to settle charges it violated the Foreign Corrupt Practices Act, without admitting or denying the allegations, the top U.S. securities regulator said on Friday.

Medical device maker Stryker to buy K2M Group for about $1.4 billion

Medical device maker Stryker Corp <SYK.N> said on Thursday it will buy smaller rival K2M Group Holdings Inc <KTWO.O> for about $1.4 billion, adding K2M's fast-growing spinal implant technology to its business.

Stryker to buy K2M Group Holdings for about $1.4 billion

Medical device maker Stryker Corp said on Thursday it will buy smaller rival K2M Group Holdings Inc for about $1.4 billion to tap into spinal device market.

BRIEF-Stryker Announces Definitive Agreement To Acquire Safeair AG

* STRYKER ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE SAFEAIR AG

Medical device maker Stryker says not in talks to buy Boston Scientific

Medical device maker Stryker Corp <SYK.N> is not in talks to buy rival Boston Scientific Corp <BSX.N>, the company said in a regulatory filing https://bit.ly/2Jy6VQB on Wednesday, two days after a media report of a potential deal between the two surfaced.

Medical device maker Stryker says not in talks to buy Boston Scientific

Medical device maker Stryker Corp was not in discussions to buy rival Boston Scientific Corp, Stryker said in a regulatory filing https://bit.ly/2Jy6VQB on Wednesday.

Medical device maker Stryker makes takeover approach to Boston Scientific: WSJ

Medical device maker Stryker Corp has made a takeover approach to rival Boston Scientific Corp, the Wall Street Journal reported on Monday, a combination that would give Stryker a strong position in stroke-preventing heart products.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Device maker Stryker has made a takeover approach to Boston Scientific - WSJ

Device maker Stryker Corp has made a takeover approach to Boston Scientific Corp, the Wall Street Journal reported https://www.wsj.com/articles/stryker-has-made-a-takeover-approach-to-boston-scientific-1528727749?mod=searchresults&page=1&pos=1, citing sources.

BRIEF-Stryker Corp Q1 Earnings Per Share $1.16

* Q1 EARNINGS PER SHARE VIEW $1.60 -- THOMSON REUTERS I/B/E/S

BRIEF-Stryker Announces Organizational Changes

* STRYKER ANNOUNCES ORGANIZATIONAL CHANGES: LONNY J. CARPENTER TO RETIRE Source text for Eikon: Further company coverage:

BRIEF-Stryker Corp Says CEO Kevin A. Lobo's 2017 Total Compensation Was $14 Million

* STRYKER CORP SAYS CEO KEVIN A. LOBO'S 2017 TOTAL COMPENSATION WAS $14 MILLION VERSUS $12.8 MILLION IN 2016 – SEC FILING Source text - http://bit.ly/2pzNhb9 Further company coverage:

BRIEF-Stryker's Spine Division Receives FDA Clearance For 3D-Printed Tritanium Tl Curved Posterior Lumbar Cage

* STRYKER'S SPINE DIVISION RECEIVES FDA CLEARANCE FOR 3D-PRINTED TRITANIUM TL CURVED POSTERIOR LUMBAR CAGE

BRIEF-Reg-Stryker Corp Announces Pricing Of $600 Million Senior Notes Offering

* REG-STRYKER CORPORATION ANNOUNCES PRICING OF $600 MILLION SENIOR NOTES OFFERING

BRIEF-Stryker Says Holds 95 Pct In Vexim; Intends To File Public Buy-Out Offer

* STRYKER CROSSES THE 95% THRESHOLDS IN VEXIM AND ANNOUNCES ITS INTENTION TO FILE A PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT FOR THE OUTSTANDING SHARES OF VEXIM

BRIEF-Stryker Crosses 95 Pct Thresholds In Vexim

* CROSSED 95 PCT THRESHOLDS IN VEXIM & INTENDS TO FILE A PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT FOR OUTSTANDING SHARES OF VEXIM

BRIEF-Stryker Declares $0.47 Per Share Quarterly Dividend

* REG-STRYKER DECLARES A $0.47 PER SHARE QUARTERLY DIVIDEND Source text for Eikon: Further company coverage:

BRIEF-Stryker Reports Q4 Earnings Per Share $1.21

* Q4 EARNINGS PER SHARE VIEW $1.95 -- THOMSON REUTERS I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up